United Kingdom · Question · Written question
UIN 45233
Cannabis: Medical Treatments
Original
Introduced
2 September 2022
Last action
21 September 2022 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
21 September 2022
Summary
To ask the Secretary of State for Health and Social Care, whether his Department has made an impact assessment of the regulations prohibiting regulated manufacture of medical cannabis and CBD products on patient safety.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
2 September 2022
Written question
To ask the Secretary of State for Health and Social Care, whether his Department has made an impact assessment of the regulations prohibiting regulated manufacture of medical cannabis and CBD products on patient safety.
Source: Commons
21 September 2022
Answer
The manufacture of cannabis-based medicines is allowed under the appropriate Medicines and Healthcare products Regulatory Agency and Home Office licences. Cannabis-based medicines must comply with all applicable requirements and high standards of manufact...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2022-09-02/45233
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1503657
- uk · wq-1503657 · source updated 21 September 2022